The Repository

Daily Elcon versus twice daily Advantan for psoriasis

Tables

Figures

Acnowledgement and disclaimer:
The Cochrane Skin Group editorial base would like to thank the authors of this study for having the courage to allow their unpublished data to be put to good use in the public domain. The Cochrane Skin Group cannot take responsibility for content contained within this unpublished study, and publishing the study on the Cochrane Skin Group website does not endorse the study in any way, nor does it suggest that it has passed any quality standards through peer review. The Cochrane Skin Group simply endorses the principle of making all data on humans that have participated in trials on skin interventions be available in the public domain.